Skip to content

Advertising disclosure: We earn commissions from some of the products we link to. It never changes our scores or what we publish. Read the full disclosure

Tom’s Weight LossRankings
Brand-nameNot tested · not scored

WebDoctors

WebDoctors

WebDoctors publishes a medical weight loss programme prescribing named FDA-approved medications — Wegovy, Ozempic, Rybelsus, Mounjaro and Zepbound — rather than unspecified 'GLP-1 medication'. Pricing was not published on the page we captured.

Sources captured · researched by Tom

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

  • Wegovy (semaglutide)FDA-approved
  • Ozempic (semaglutide)FDA-approved
  • Rybelsus (oral semaglutide)FDA-approved
  • Mounjaro (tirzepatide)FDA-approved
  • Zepbound (tirzepatide)FDA-approved

What they publish

WebDoctors publishes 0 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee
Pricing was not published on the page we captured
Medication cost
Not publicly disclosed on the pages we captured.
Introductory offer
Not publicly disclosed on the pages we captured.
Insurance
Not publicly disclosed on the pages we captured.
HSA / FSA
Not publicly disclosed on the pages we captured.
Consultation process
Not publicly disclosed on the pages we captured.
Eligibility
Not publicly disclosed on the pages we captured.
Lab work
Not publicly disclosed on the pages we captured.
Pharmacy fulfilment
Not publicly disclosed on the pages we captured.
Shipping
Not publicly disclosed on the pages we captured.
Support services
Not publicly disclosed on the pages we captured.
Cancellation
Not publicly disclosed on the pages we captured.
Refunds
Not publicly disclosed on the pages we captured.

What stands out

  • Names each FDA-approved product individually rather than advertising generic 'GLP-1 medication', which removes the ambiguity most of this directory leaves open.
  • Includes Rybelsus, the oral semaglutide product, which is approved for type 2 diabetes rather than weight management — a distinction worth raising with the prescriber.
  • No compounded products advertised.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

  • Establish the consultation and programme cost, which was not published.
  • If offered Rybelsus or Ozempic for weight loss, understand that is off-label prescribing and ask why it is being chosen.

Limitations

  • No pricing published.

Sources

Captured . Pages change — check the current version before relying on anything here.

Worth comparing against

Brand-nameInsurance support

MDLIVE

MDLIVE (Evernorth)

Major insurer-backed telehealth that states plainly it never uses compounded medication

Membership
Not published
Medication
Not published
Publishes2/12 terms
Brand-nameInsurance support

PlushCare

PlushCare (Accolade)

Primary-care physicians, FDA-approved medication, insurance accepted and no minimum commitment

Membership
Not published
Medication
Billed separately
Publishes7/12 terms
Brand-name

Sesame

Sesame Care

Marketplace of independent clinicians offering weight loss appointments

Membership
Not published
Medication
Not published
Publishes0/12 terms